Addressing One of Healthcare’s Largest Problems
The rapid emergence of resistant bacteria is endangering the efficacy of antibiotics, thus causing a serious threat to global health care.
Each year in the US alone, at least 2 million people become infected with drug-resistant bacteria, and 23,000 people die as a direct result.
ArcDia’s mariAST® is the most promising diagnostic platform to tackle antibiotic resistance. It is rapid, easy-to-use and cost-effective. mariAST allows near-patient analysis directly from clinical samples without isolation of the bacteria strain.
ArcDia’s mariAST® is based on ArcDia’s mariPOC® field-proven test system. The mariPOC® product line for multianalyte testing of acute infections covers viruses and bacteria for the most common respiratory infections and for gastroenteritis.
mariPOC® ensures lower probability for C. difficile misdiagnosis with precision mariPOC® CDI test is a…
ArcDia Scientific Feed New research data shows that influenza antigen testing correlates best with the…